Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension

Thrombosis and Haemostasis

Volumn 83, Issue 5, 2000, Pages 683-687

  Lopes, Antonio Augusto ^a,b   Ferraz De Souza, Bruno ^c   Maeda, Nair Yukie ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDAÇÃO PRÓ SANGUE HEMOCENTRO DE SÃO PAULO   (Brazil)

^c NONE

Author keywords

Pulmonary hypertension; Sialic acid; Von Willebrand factor

Indexed keywords

SIALIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VON WILLEBRAND FACTOR; WHEAT GERM AGGLUTININ;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCHOOL CHILD; SPECTROPHOTOMETRY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

EID: 0034066655     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613892     Document Type: Article

References (28)

1. Osawa T, Tsuji T. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Ann Rev Biochem 1987; 56: 21-42.
2. Gahmberg CG, Tolvanen M. Why mammalian cell surface proteins are glycoproteins. Trends Biochem Sci 1996; 21: 308-11.
3. Aminoff D. The role of sialoglycoconjugates in the aging and sequestration of red cells from circulation. Blood Cells 1988; 14: 229-47.
4. Kotzé HF, van Wyk V, Badenhorst PN, Heyns AP, Roodt JP, Lötter MG. Influence of platelet membrane sialic acid and platelet-associated IgG on ageing and sequestration of blood platelets in baboons. Thromb Haemost 1993; 70(4): 676-80.
5. Chopek MW, Girma J-P, Fujikawa K, Davie EW, Titani K. Human von Willebrand factor: A multivalent protein composed of identical subunits. Biochemistry 1986; 25: 3146-55.
6. Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, Walsh KA, Chopek MW, Sadler JE, Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 3171-84.
7. Bastida E, Monteagudo J, Ordinas A, De Marco L, Castillo R. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium. Thromb Haemost 1988; 60: 30-4.
8. Berkowitz SD, Federici AB. Sialic acid prevents loss of large von Willebrand factor multimers by protecting against amino-terminal proteolytic cleavage. Blood 1988; 72 (5): 1790-6.
9. Federici AB, De Romeuf C, De Groot PG, Samor B, Lombardi R, D'Alessio P, Mazurier C, Mannucci PM, Sixma JJ. Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF). Blood 1988; 71 (4): 947-52.
10. Rabinovitch M, Andrew M, Thom H, Trusler GA, Williams WG, Rowe RD, Olley PM. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects. Circulation 1987; 76: 1043-52.
11. Lopes AAB, Maeda NY, Aiello VD, Ebaid M, Bydlowski SP. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension. Chest 1993; 104: 1455-60.
12. Gralnick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y. von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. J Clin Invest 1985; 76 (4): 1522-9.
13. Maeda NY, Bydlowski SP, Lopes AAB. Sialic acid content of von Willebrand factor subunit. A simple method for quantitative estimation. Clin Chim Acta 1998; 273: 209-11.
14. Aminoff D. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoides. Biochem J 1961; 81: 384-92.
15. Debeire P, Montreuil J, Samor B, Mazurier C, Goudemand M, van Halbeek H, Vliegenthart JF. Structure determination of the major asparagine-linked sugar chain of human factor VIII-von Willebrand factor. FEBS Lett 1983; 151 (1): 22-6.
16. Samor B, Michalski JC, Mazurier C, Goudemand M, De Waard P, Vliegenthart JF, Strecker G, Montreuil J. Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor. Glycoconj J 1989; 6 (3): 263-70.
17. Matsui T, Kihara C, Fujimura Y, Mizuochi T, Tilani K. Carbohydrate analysis of human von Willebrand factor with horseradish peroxidase-conjugated lectins. Biochem Biophys Res Commun 1991; 178 (3): 1253-9.
18. Rostagno C, Boddi PM, Poggesi L. Evidence for local platelet activation in pulmonary vessels in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease. Eur Respir J 1991; 4: 147-51.
19. Lopes AAB, Maeda NY, Almeida A, Jaeger R, Ebaid M, Chamone DAF. Circulating platelet aggregates indicative of in vivo platelet activation in pulmonary hypertension. Angiology 1993; 44: 701-6.
20. Lopes AAB, Maeda NY, Ebaid M, Chamone DAF, Pileggi F. Effect of intentional hemodilution on platelet survival in secondary pulmonary hypertension. Chest 1989; 95: 1207-10.
21. De Marco L, Girulami A, Russell S, Ruggeri ZM. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. J Clin Invest 1985; 75 (4): 1198-203.
22. Goudemand J, Mazurier C, Samor B, Bouquelet S, Montreuil J, Goudemand M. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets. Thromb Haemost 1985; 53 (3): 390-5.
23. Räbinä J, Pikkarainen M, Miyasaka M, Renkonen R. A time-resolved immunofluorometric assay of sialyl Lewis x-degrading α2.3-sialidase activity. Anal Biochem 1998; 258: 362-8.
24. van der Spoel A, Bonten E, d'Azzo A. Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A. EMBO J 1998; 17 (6): 1588-97.
25. Crestani B, Dehoux M, Seta N, Cuer M, Aubier M. Cell surface carbohydrates of rat alveolar type II cells in primary culture. Am J Respir Cell Mol Biol 1993; 8: 145-52.
26. Guthridge JM, Kaplan AM, Cohen DA. Regulalion of B cell: T cell interactions: potential involvement of an endogenous B cell sialidase. Immunol Invest 1994; 23 (6-7): 393-411.
27. Hanson VA, Shettigar UR, Loungani RR, Nadijcka MD. Plasma sialidase activity in acute myocardial infarction. Am Heart J 1987; 114: 59-63.
28. Lopes AAB, Maeda NY. Abnormal degradation of von Willebrand factor main subunit in pulmonary hypertension. Eur Resp J 1995; 8: 530-6.